Replimune Stock Forecast - Price Action Indicator

REPL Stock  USD 7.71  0.19  2.41%   
Replimune Stock Forecast is based on your current time horizon. Although Replimune's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Replimune's systematic risk associated with finding meaningful patterns of Replimune fundamentals over time.
As of now the rsi of Replimune's share price is below 20 indicating that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of Replimune's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Replimune and does not consider all of the tangible or intangible factors available from Replimune's fundamental data. We analyze noise-free headlines and recent hype associated with Replimune Group, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Replimune's stock price prediction:
EPS Estimate Next Quarter
(0.70)
EPS Estimate Current Year
(3.37)
EPS Estimate Next Year
(2.06)
Wall Street Target Price
12.5714
EPS Estimate Current Quarter
(0.79)
Using Replimune hype-based prediction, you can estimate the value of Replimune Group from the perspective of Replimune response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Replimune using Replimune's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Replimune using crowd psychology based on the activity and movement of Replimune's stock price.

Replimune Implied Volatility

    
  2.02  
Replimune's implied volatility exposes the market's sentiment of Replimune Group stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Replimune's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Replimune stock will not fluctuate a lot when Replimune's options are near their expiration.

Replimune after-hype prediction price

    
  USD 7.66  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Replimune to cross-verify your projections.

Prediction based on Rule 16 of the current Replimune contract

Based on the Rule 16, the options market is currently suggesting that Replimune Group will have an average daily up or down price movement of about 0.13% per day over the life of the 2026-04-17 option contract. With Replimune trading at USD 7.71, that is roughly USD 0.009734 . If you think that the market is fully incorporating Replimune's daily price movement you should consider acquiring Replimune Group options at the current volatility level of 2.02%. But if you have an opposite viewpoint you should avoid it and even consider selling them.

Open Interest Against 2026-04-17 Replimune Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Replimune's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Replimune's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Replimune stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Replimune's open interest, investors have to compare it to Replimune's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Replimune is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Replimune. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.

Replimune Additional Predictive Modules

Most predictive techniques to examine Replimune price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Replimune using various technical indicators. When you analyze Replimune charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Replimune Group has current Price Action Indicator of (0.08). Price Action indicator evaluates an asset for a given trading period using the following formula: ((close - open) + (close - high) + (close - low)) / 2. This indicator is consistent with the interpretation of Japanese candlestick patterns.
Check Replimune VolatilityBacktest ReplimuneInformation Ratio  

Replimune Trading Date Momentum

On January 25 2026 Replimune Group was traded for  7.71  at the closing time. The top price for the day was 7.85  and the lowest listed price was  7.54 . There was no trading activity during the period 0.0. Lack of trading volume on January 25, 2026 did not cause price change. The trading delta at closing time against the current closing price is 1.43% .
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
Compare Replimune to competition

Other Forecasting Options for Replimune

For every potential investor in Replimune, whether a beginner or expert, Replimune's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Replimune Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Replimune. Basic forecasting techniques help filter out the noise by identifying Replimune's price trends.

Replimune Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Replimune stock to make a market-neutral strategy. Peer analysis of Replimune could also be used in its relative valuation, which is a method of valuing Replimune by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Replimune Market Strength Events

Market strength indicators help investors to evaluate how Replimune stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Replimune shares will generate the highest return on investment. By undertsting and applying Replimune stock market strength indicators, traders can identify Replimune Group entry and exit signals to maximize returns.

Replimune Risk Indicators

The analysis of Replimune's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Replimune's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting replimune stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Story Coverage note for Replimune

The number of cover stories for Replimune depends on current market conditions and Replimune's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Replimune is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Replimune's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Replimune Short Properties

Replimune's future price predictability will typically decrease when Replimune's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Replimune Group often depends not only on the future outlook of the potential Replimune's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Replimune's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding80.6 M
Cash And Short Term Investments483.8 M
When determining whether Replimune Group is a strong investment it is important to analyze Replimune's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Replimune's future performance. For an informed investment choice regarding Replimune Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Replimune to cross-verify your projections.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Replimune. If investors know Replimune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Replimune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.47)
Return On Assets
(0.45)
Return On Equity
(0.96)
The market value of Replimune Group is measured differently than its book value, which is the value of Replimune that is recorded on the company's balance sheet. Investors also form their own opinion of Replimune's value that differs from its market value or its book value, called intrinsic value, which is Replimune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Replimune's market value can be influenced by many factors that don't directly affect Replimune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Replimune's value and its price as these two are different measures arrived at by different means. Investors typically determine if Replimune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Replimune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.